Filcad

Filcad is a recombinant **filgrastim** product used to reduce or prevent chemotherapy-induced neutropenia by stimulating neutrophil production in the bone marrow. It is a **granulocyte colony-stimulating factor** biologic that acts as an agonist of the **G-CSF receptor** on hematopoietic progenitor cells, promoting proliferation, differentiation, and survival of neutrophil precursors. Based on the provided context, Filcad is administered by injection and is used primarily in oncology supportive care to lower the risk of infection after myelosuppressive chemotherapy; the related long-acting product Filcad P contains pegfilgrastim and is a distinct formulation/product rather than Filcad itself.

Brand names

Filcad